Venissieux, France

Karine Chemin

USPTO Granted Patents = 2 


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Karine Chemin: Innovator in Cancer Treatment

Introduction

Karine Chemin is a prominent inventor based in Venissieux, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic methods. With a total of 2 patents, her work focuses on the detection and treatment of TLR3-positive cancer.

Latest Patents

Karine's latest patents include groundbreaking methods for treating patients with TLR3-positive cancer. The first patent relates to antibodies, antibody fragments, and derivatives that specifically bind to TLR3 cell receptors present on the surface of cells. This invention also encompasses hybridomas that produce such antibodies, methods for their production, and pharmaceutical compositions that include these antibodies. Additionally, it outlines methods for using these antibodies to detect TLR3 levels on cell surfaces, which can be utilized for diagnostic or therapeutic purposes.

The second patent similarly focuses on compositions and methods for detecting TLR3. It details the same innovative approaches involving antibodies and their derivatives, emphasizing their potential in both diagnostic and therapeutic applications for patients.

Career Highlights

Karine Chemin is currently associated with Innate Pharma, a company dedicated to developing innovative immunotherapies for cancer treatment. Her work at Innate Pharma has positioned her as a key player in the advancement of cancer therapies, particularly those targeting TLR3.

Collaborations

Throughout her career, Karine has collaborated with notable colleagues, including Laurent Gauthier and Yannis Morel. These collaborations have further enriched her research and contributed to the development of effective cancer treatment methods.

Conclusion

Karine Chemin's contributions to cancer treatment through her innovative patents and collaborations highlight her significant role in the field. Her work continues to pave the way for advancements in therapeutic methods for TLR3-positive cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…